{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":85,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":85,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"3276d03249a7","filters":{"venue":"Inpharma Weekly"}},"results":[{"id":"W4249598482","doi":"10.1007/bf03272663","title":"Atorvastatin calcium approved in Canada for MI prevention","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Pharmacy; Pharmacology; Internal medicine; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01454379219708397,"gpt":0.2792005168786046,"spread":0.2646567246815206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004443776,0.0002737794,0.0005130194,0.0008536096,0.001157655,0.001020066,0.0005835518,0.0009595933,0.01563345],"category_scores_gemma":[0.001702481,0.0001743019,0.0006152432,0.001285594,0.0004988865,0.000207767,0.0003135611,0.001725268,0.001970691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008069294,"about_ca_system_score_gemma":0.03045137,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.659989,"about_ca_topic_score_gemma":0.8476559,"domain_scores_codex":[0.9993112,0.0001146105,0.0000456337,0.0000594909,0.0002350984,0.0002339405],"domain_scores_gemma":[0.9985766,0.0001095575,0.0001519269,0.00003460393,0.0007363908,0.0003908632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01208706,0.001051025,0.05425921,0.001669523,0.000653788,0.002678377,0.0002408833,0.0005982,0.02453396,0.01621692,0.410524,0.4754871],"study_design_scores_gemma":[0.005066925,0.001574479,0.1102438,0.0007982217,0.0007370648,0.001876134,0.0002263621,0.000714242,0.007067889,0.001093701,0.8705276,0.0000737352],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.1951299,0.1203084,0.006091506,0.1061244,0.007959762,0.00144601,0.02788775,0.002225539,0.5328268],"genre_scores_gemma":[0.7335276,0.04119563,0.008895393,0.02161621,0.00147905,0.000366559,0.01301322,0.0002522772,0.1796541],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.340011,"threshold_uncertainty_score":0.6840268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239531242","doi":"10.2165/00128413-200414290-00064","title":"The Therapeutic Products Directorate of Health Canada has approved gemifloxacin","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Gemifloxacin; Medicine; Pharmacy; Environmental health; Family medicine; Moxifloxacin; Microbiology; Antibiotics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.3939423323082523,"gpt":0.4025350128563726,"spread":0.008592680548120346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004579984,0.0004391793,0.0007143231,0.001534028,0.001660765,0.001975611,0.00120852,0.003964651,0.01986388],"category_scores_gemma":[0.009384239,0.0003627396,0.001004557,0.001182581,0.0009396999,0.0004517749,0.000407112,0.002962639,0.003795016],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01173801,"about_ca_system_score_gemma":0.05123117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4322423,"about_ca_topic_score_gemma":0.696483,"domain_scores_codex":[0.996687,0.0008136004,0.0001684154,0.0001495448,0.001536539,0.0006450276],"domain_scores_gemma":[0.9835141,0.002074661,0.001063193,0.0003528502,0.01035699,0.002638243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003065146,0.0004777908,0.01487906,0.0007161547,0.0001216978,0.0008844021,0.0001174788,0.0005045605,0.008917185,0.004543911,0.7331522,0.2326204],"study_design_scores_gemma":[0.0006778891,0.001005295,0.01826075,0.0002469806,0.0001523758,0.0006080907,0.0001240894,0.0007503233,0.006600969,0.0002693966,0.9712625,0.00004127813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.08570343,0.05670136,0.008140403,0.3617911,0.01697405,0.002964789,0.02534005,0.002247048,0.4401378],"genre_scores_gemma":[0.3197269,0.02147801,0.01197886,0.06577463,0.004259257,0.000303577,0.01138892,0.000359927,0.5647299],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.988262,"threshold_uncertainty_score":0.8594528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252046852","doi":"10.2165/00128413-200715940-00063","title":"Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cannabidiol; Dronabinol; Medicine; Notice; Pharmacy; Cannabis; Family medicine; Psychiatry; Law; Internal medicine; Cannabinoid; Political science","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05891339858623662,"gpt":0.3702996354452724,"spread":0.3113862368590358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005187426,0.0006550805,0.0009938172,0.002148503,0.007243187,0.003872953,0.002229618,0.01217134,0.05196366],"category_scores_gemma":[0.01083027,0.0007758167,0.001325444,0.0009232229,0.002449395,0.000643739,0.0008653991,0.007199239,0.01061931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01169589,"about_ca_system_score_gemma":0.07711437,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4820317,"about_ca_topic_score_gemma":0.7892988,"domain_scores_codex":[0.9938293,0.0004302279,0.0001715456,0.0002804757,0.004041118,0.001247282],"domain_scores_gemma":[0.9847372,0.002597683,0.0003842371,0.0004795643,0.00921153,0.002589766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004515871,0.0003050021,0.002183909,0.0002359071,0.00004568076,0.00121686,0.000157457,0.00008349244,0.006029047,0.006735234,0.9399725,0.04258326],"study_design_scores_gemma":[0.0002213322,0.0002619659,0.007069495,0.00008992256,0.00006370975,0.0003869028,0.0001420774,0.0002605962,0.003611538,0.0004897543,0.9873577,0.00004501519],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.02679077,0.0101535,0.004924391,0.1781645,0.03118816,0.004040627,0.008510727,0.002794598,0.7334328],"genre_scores_gemma":[0.04716375,0.002778792,0.003943773,0.06067496,0.002625087,0.0002293963,0.002699778,0.0003173512,0.8795671],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.5179683,"threshold_uncertainty_score":0.9584519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230288979","doi":"10.2165/00128413-200816200-00047","title":"New warnings for Alertec in Canada","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Risk and Safety Analysis","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.117417564449509,"gpt":0.3544687148965894,"spread":0.2370511504470804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003265822,0.0004650171,0.0004432237,0.002389087,0.003063528,0.005041046,0.001274168,0.004800429,0.02053449],"category_scores_gemma":[0.0148927,0.0004186021,0.0008128803,0.002089955,0.001042411,0.001257316,0.001006491,0.005225928,0.001776536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.035902,"about_ca_system_score_gemma":0.1028862,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9612557,"about_ca_topic_score_gemma":0.9789645,"domain_scores_codex":[0.9942855,0.0002445481,0.0002557656,0.0002233282,0.00407335,0.0009175103],"domain_scores_gemma":[0.9767427,0.002320257,0.001001489,0.000336321,0.01690019,0.002699033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003250421,0.0000778074,0.0220991,0.0002412858,0.00002993987,0.0006337432,0.0005178463,0.0009546906,0.0008129199,0.008780201,0.8971171,0.06841043],"study_design_scores_gemma":[0.0001104822,0.0001251076,0.08030228,0.0004358039,0.00006770885,0.0002470598,0.00124281,0.003557817,0.001118086,0.001820683,0.9108894,0.000082801],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.1003121,0.01501045,0.007890802,0.5006491,0.02686921,0.0005601509,0.01724555,0.003243776,0.3282189],"genre_scores_gemma":[0.416566,0.009467581,0.008381314,0.09201696,0.003269241,0.0001504141,0.00658498,0.0005372129,0.4630264],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.03874433,"threshold_uncertainty_score":0.2604885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4250267269","doi":"10.2165/00128413-200112860-00058","title":"Recent approvals in the Canadian market","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02371898196635164,"gpt":0.279133966060813,"spread":0.2554149840944613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00317962,0.0006478321,0.0006351229,0.002624939,0.003021063,0.00427662,0.001045902,0.003220703,0.07014246],"category_scores_gemma":[0.01124171,0.0002651987,0.001005031,0.002877024,0.001892788,0.001056168,0.0006962002,0.003071034,0.009172907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02313244,"about_ca_system_score_gemma":0.0422014,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6633904,"about_ca_topic_score_gemma":0.8194538,"domain_scores_codex":[0.9951878,0.0002412539,0.0001325196,0.0003140602,0.003262399,0.0008619956],"domain_scores_gemma":[0.9869767,0.0009717253,0.0004093294,0.0002753306,0.009574145,0.001792676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005098706,0.0001141487,0.002998943,0.0007763325,0.00004700946,0.0006125628,0.0002486622,0.0001875312,0.001920296,0.01308361,0.7734011,0.2060999],"study_design_scores_gemma":[0.0000532848,0.0000634789,0.006154294,0.0001694871,0.00003744948,0.0001950152,0.000137396,0.00007528205,0.0006071925,0.0003576293,0.9921306,0.00001893026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01819804,0.07294957,0.001752232,0.09859438,0.01469363,0.0004210884,0.00644527,0.0007128214,0.7862329],"genre_scores_gemma":[0.2173437,0.0811772,0.003552059,0.04938497,0.005934408,0.0002114969,0.007082501,0.0003991503,0.6349144],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3366096,"threshold_uncertainty_score":0.6771839,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210528054","doi":"10.2165/00128413-200715730-00068","title":"A pravastatin/aspirin combination therapy [PravASA; Paladin Labs] has been launched in Canada.","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Pravastatin; Aspirin; Pharmacy; Family medicine; Internal medicine; Engineering","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03224183768008571,"gpt":0.2847662141551547,"spread":0.252524376475069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001142306,0.0004628704,0.001109203,0.001037024,0.00204959,0.00134633,0.0008599153,0.001713416,0.02942769],"category_scores_gemma":[0.0009090114,0.0002103106,0.0006549312,0.001002764,0.0007872506,0.000311567,0.0005771531,0.002193719,0.005164107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004153568,"about_ca_system_score_gemma":0.0189536,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3279732,"about_ca_topic_score_gemma":0.6409236,"domain_scores_codex":[0.9990588,0.00009785715,0.0000311797,0.00009789225,0.0005074141,0.0002067519],"domain_scores_gemma":[0.9981212,0.0001306594,0.00007524878,0.00003573459,0.0006574463,0.0009797892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00677875,0.00272177,0.02558196,0.0009500946,0.0002479899,0.002028339,0.0001763804,0.0002610298,0.02724782,0.002756437,0.2667203,0.6645292],"study_design_scores_gemma":[0.004088508,0.005745245,0.08805626,0.0003451398,0.0005006377,0.002398732,0.0003302726,0.001029812,0.01030291,0.0007131066,0.8863875,0.0001018971],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.2164185,0.1271708,0.008580557,0.1071866,0.009677464,0.004225888,0.01448052,0.005849033,0.5064107],"genre_scores_gemma":[0.5184692,0.05330801,0.02239476,0.03094481,0.003036904,0.0007367734,0.0115904,0.0006511648,0.358868],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.6720268,"threshold_uncertainty_score":0.6521284,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.007872528325920655,"gpt":0.2359594050837431,"spread":0.2280868767578225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001084627,0.0002789182,0.0005473522,0.0007146945,0.001596525,0.0009405006,0.0009765937,0.001790368,0.01131008],"category_scores_gemma":[0.00150789,0.0002196895,0.0005922221,0.0007041989,0.0006664498,0.0002057263,0.000279719,0.001679755,0.001989297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006778314,"about_ca_system_score_gemma":0.02178132,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3317898,"about_ca_topic_score_gemma":0.6820464,"domain_scores_codex":[0.9992901,0.0001499784,0.00003195988,0.00004993218,0.0002888262,0.0001892022],"domain_scores_gemma":[0.9977747,0.0004185687,0.0001645585,0.00006202215,0.0008075729,0.0007726105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003665701,0.001108587,0.05136814,0.0008117294,0.0002562806,0.002749921,0.0002669351,0.0007076475,0.02669735,0.003401357,0.3166892,0.5922771],"study_design_scores_gemma":[0.002725673,0.003489047,0.08202838,0.0003278429,0.0004320825,0.003554027,0.0001884871,0.001114631,0.01019714,0.0003548476,0.895526,0.00006182774],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.303723,0.1068666,0.006902311,0.107316,0.005249604,0.002329593,0.008229656,0.002698202,0.4566851],"genre_scores_gemma":[0.7285475,0.0285952,0.01797551,0.03731734,0.001797209,0.0004046015,0.006911994,0.0003604037,0.1780903],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.6682102,"threshold_uncertainty_score":0.6597171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241551250","doi":"10.2165/00128413-200816220-00084","title":"Frovatriptan [Frova; Teva Neuroscience Canada] has been launched in Canada for the treatment of migraines with or without aura in adults.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Aura; Medicine; Pharmacy; Launched; Family medicine; Psychiatry; Migraine; Engineering","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05994279408294232,"gpt":0.2833808924903209,"spread":0.2234380984073786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006713354,0.0002552222,0.000555527,0.0003838454,0.0009275834,0.0006035115,0.0004710024,0.0005193496,0.01380732],"category_scores_gemma":[0.001054677,0.0001217628,0.0003372311,0.0007487069,0.0003451742,0.0002274893,0.00033848,0.0008769241,0.0009691446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001997887,"about_ca_system_score_gemma":0.005508078,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1729503,"about_ca_topic_score_gemma":0.4101877,"domain_scores_codex":[0.9996852,0.00008418866,0.00002025521,0.00002953159,0.0001201524,0.00006074416],"domain_scores_gemma":[0.9993124,0.0001607367,0.0001248909,0.00002873368,0.0001625768,0.0002107242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02242147,0.002416174,0.06297757,0.005982163,0.001083447,0.002937746,0.0006044347,0.0004605454,0.03489328,0.005025359,0.1453241,0.7158737],"study_design_scores_gemma":[0.01032573,0.01654407,0.2877161,0.001462404,0.001151773,0.005474906,0.0008130235,0.0003947221,0.01091526,0.001114697,0.66399,0.00009739647],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.4951727,0.1970373,0.001281034,0.01736687,0.001622161,0.001786509,0.018176,0.0002906159,0.2672668],"genre_scores_gemma":[0.8127909,0.1023516,0.003928713,0.007340733,0.001107443,0.000420501,0.008265004,0.00006591138,0.06372908],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.8270497,"threshold_uncertainty_score":0.3438872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244553985","doi":"10.2165/00128413-200715720-00069","title":"Cangene Corporation's hepatitis B immune globulin [HepaGam] has been granted a Notice of Compliance with condition by Health Canada,","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Hepatitis B immune globulin; Compliance (psychology); Corporation; Pharmacy; Family medicine; Immunology; Chronic hepatitis; Law; Political science; Social psychology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03727338411076089,"gpt":0.3000161753463018,"spread":0.2627427912355409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002799128,0.0003083028,0.0004271776,0.00100711,0.00315855,0.00237025,0.0007601912,0.002980467,0.1149636],"category_scores_gemma":[0.008279319,0.0003645171,0.0003678991,0.0006869959,0.001059732,0.0003715296,0.0006312378,0.002137515,0.04084219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003420541,"about_ca_system_score_gemma":0.0191753,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.143522,"about_ca_topic_score_gemma":0.4014922,"domain_scores_codex":[0.9975117,0.0003012968,0.00008926529,0.0001280599,0.001594558,0.0003751298],"domain_scores_gemma":[0.9948943,0.001055456,0.0001663015,0.000514906,0.0024412,0.000927932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004626682,0.0003603934,0.003019122,0.00008008492,0.00001601533,0.0001484835,0.0001020528,0.00004102796,0.00258338,0.004363516,0.9315078,0.05731555],"study_design_scores_gemma":[0.0001523158,0.0002746052,0.01005285,0.0000457229,0.00001725824,0.0001825487,0.00009202676,0.0000871809,0.002589063,0.0002183972,0.9862757,0.00001236779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.02150387,0.004593463,0.001066947,0.04237248,0.00949533,0.001029051,0.006105498,0.001829821,0.9120035],"genre_scores_gemma":[0.02163059,0.0006767518,0.0009159828,0.005763969,0.0003672365,0.00008176473,0.001843286,0.0001538216,0.9685666],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.856478,"threshold_uncertainty_score":0.3845914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252472898","doi":"10.2165/00128413-200213410-00052","title":"Recent product approvals in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.4417186797614878,"gpt":0.3969668101560449,"spread":0.04475186960544286,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002858837,0.0005992431,0.0007453351,0.003602497,0.002792128,0.004873227,0.001034607,0.002666196,0.04819506],"category_scores_gemma":[0.009293293,0.0004090253,0.001084904,0.00336855,0.001309774,0.0007748392,0.0005836046,0.002737379,0.01023798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02116257,"about_ca_system_score_gemma":0.04312182,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8458661,"about_ca_topic_score_gemma":0.9067248,"domain_scores_codex":[0.9948896,0.0002096454,0.0001825994,0.0003020238,0.003766738,0.0006492891],"domain_scores_gemma":[0.9831402,0.000745095,0.0004993911,0.0002717761,0.01401202,0.001331525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005267345,0.00008950393,0.004569137,0.0005319531,0.00004519349,0.0002664137,0.0001391199,0.0002523745,0.001069686,0.002805988,0.8738916,0.1158123],"study_design_scores_gemma":[0.00005216243,0.00007464935,0.01922843,0.0001557631,0.0000504682,0.00009282443,0.0001262643,0.0001905487,0.0009831123,0.0001685937,0.9788529,0.000024327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0364783,0.07263007,0.002466411,0.0598929,0.02326053,0.0009838919,0.04261583,0.001623949,0.7600482],"genre_scores_gemma":[0.1291171,0.02723995,0.001747635,0.01472346,0.002121892,0.0002229854,0.01620483,0.0004799539,0.8081421],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1541339,"threshold_uncertainty_score":0.3100833,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243923408","doi":"10.2165/00128413-200113150-00052","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02023096354187482,"gpt":0.2872669464453149,"spread":0.2670359829034401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001010061,0.0008728373,0.0007528544,0.002308494,0.006336105,0.01194641,0.001046048,0.005261838,0.1964562],"category_scores_gemma":[0.003234266,0.0005537382,0.0006459007,0.003320371,0.001008232,0.001633372,0.001076938,0.003957405,0.05921591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0203446,"about_ca_system_score_gemma":0.03814969,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.838168,"about_ca_topic_score_gemma":0.9374605,"domain_scores_codex":[0.9980612,0.00004979416,0.00003708599,0.0001334278,0.001235848,0.0004825268],"domain_scores_gemma":[0.9971848,0.0002041979,0.00007535526,0.0001128369,0.00186323,0.0005595318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001303742,0.000005345266,0.000108252,0.00002034363,0.00000124684,0.00002319103,0.00002121583,0.00001381265,0.00002748472,0.001192219,0.9938869,0.004686881],"study_design_scores_gemma":[0.000005589184,0.000003386373,0.001229285,0.00003303028,0.000002409354,0.000009204431,0.00009893017,0.00002470791,0.00004936039,0.0001492477,0.9983894,0.000005543192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.002846811,0.01559398,0.0002047394,0.1036445,0.02272904,0.0001022543,0.009752302,0.0005340647,0.8445922],"genre_scores_gemma":[0.004471176,0.002044687,0.00006449746,0.005874591,0.000665316,0.00001340168,0.001088324,0.00006946974,0.9857085],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1964562,"threshold_uncertainty_score":0.6572115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247698475","doi":"10.2165/00128413-200615670-00056","title":"Health Canada updates information about Tamiflu","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Health information; Medical emergency; Environmental health; Family medicine; Health care; Economic growth","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1286754122059632,"gpt":0.3766125392026163,"spread":0.2479371269966532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00139492,0.0008295355,0.001103278,0.006184593,0.001941039,0.002790188,0.001538591,0.002534165,0.2989499],"category_scores_gemma":[0.006729634,0.0004469157,0.0007340127,0.006131661,0.000462606,0.0007695206,0.0008714063,0.001461437,0.06988432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01331455,"about_ca_system_score_gemma":0.04207547,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8108612,"about_ca_topic_score_gemma":0.8989624,"domain_scores_codex":[0.9986921,0.0000872433,0.00007353913,0.00006411505,0.0007966273,0.0002864436],"domain_scores_gemma":[0.9912492,0.001506101,0.0004180421,0.0002532351,0.005115085,0.001458321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004267816,0.00001519245,0.0003117139,0.00008017311,0.000003148572,0.00002024078,0.000007819227,0.0000264625,0.00002661006,0.0001222074,0.9862534,0.01309034],"study_design_scores_gemma":[0.00007238152,0.0000259516,0.005154192,0.0001518222,0.00001770841,0.00002828331,0.00006530712,0.0001775552,0.00013348,0.0001259309,0.9940311,0.00001622525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.005417492,0.01274658,0.0005978243,0.06346761,0.0105372,0.0007532469,0.3065434,0.004476815,0.5954599],"genre_scores_gemma":[0.01084685,0.006232044,0.001204485,0.01711508,0.001368161,0.0003054554,0.04578423,0.0005247708,0.9166189],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.8108612,"threshold_uncertainty_score":0.9999629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248864116","doi":"10.2165/00128413-200816340-00055","title":"Health Canada issues foreign product alert","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Medical emergency; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05127717373382897,"gpt":0.3116325408963768,"spread":0.2603553671625479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001938929,0.001277432,0.001769284,0.00435133,0.004936198,0.006831382,0.002477629,0.0251015,0.2024002],"category_scores_gemma":[0.01115308,0.0009324383,0.001884578,0.003072132,0.001267432,0.001416805,0.00148213,0.008328458,0.0742195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01407448,"about_ca_system_score_gemma":0.04940649,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5940145,"about_ca_topic_score_gemma":0.7417433,"domain_scores_codex":[0.9958269,0.0001613426,0.0002192659,0.0001718427,0.002879891,0.0007406742],"domain_scores_gemma":[0.9827372,0.001699727,0.0005365641,0.0004659812,0.01082531,0.003735296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000007870992,0.00001368026,0.0002114003,0.00001633124,0.000001663591,0.00003783745,0.000003168205,0.000008502589,0.000008909821,0.0000626296,0.9965562,0.003071965],"study_design_scores_gemma":[0.0000322951,0.00001454589,0.003502951,0.0000904336,0.00001206181,0.00005850845,0.00007852963,0.00009246974,0.00006203467,0.0001753996,0.9958673,0.00001354331],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.002173045,0.004280209,0.0003572003,0.4419615,0.133664,0.0006600822,0.02536735,0.001966428,0.3895701],"genre_scores_gemma":[0.003996767,0.002789924,0.0002863986,0.1118305,0.01667439,0.0001354589,0.005188042,0.0001949492,0.8589035],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.4059855,"threshold_uncertainty_score":0.8167528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239700607","doi":"10.2165/00128413-200816490-00061","title":"Idebenone approved in Canada, but EU needs more data","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Idebenone; Family medicine; Pharmacology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.5159014374493767,"gpt":0.4176488603409993,"spread":0.09825257710837737,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005793657,0.0008127452,0.002347896,0.001192896,0.001175997,0.003600822,0.001659182,0.003762051,0.01534703],"category_scores_gemma":[0.00624422,0.0004099575,0.00176286,0.002289336,0.001121278,0.001152202,0.0006590842,0.004437794,0.003350658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01172806,"about_ca_system_score_gemma":0.04454896,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3889381,"about_ca_topic_score_gemma":0.5571774,"domain_scores_codex":[0.9964515,0.0009602187,0.0003633009,0.0003894061,0.001125312,0.000710363],"domain_scores_gemma":[0.9912493,0.0009376616,0.0008610492,0.0003993633,0.005154636,0.001397877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01805595,0.0006684948,0.01206384,0.003097616,0.0009376176,0.0008952626,0.0001208895,0.001471995,0.007319276,0.007804406,0.5737917,0.3737731],"study_design_scores_gemma":[0.007010724,0.002829176,0.0250982,0.002206425,0.001009943,0.0004983228,0.0001982159,0.000488492,0.006166214,0.002274778,0.9520924,0.0001271683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.07606115,0.1650974,0.006983673,0.2450577,0.02085141,0.00275503,0.1399485,0.001311564,0.3419337],"genre_scores_gemma":[0.4358456,0.1038232,0.01795045,0.1621747,0.004090578,0.002313175,0.09608097,0.0008784456,0.1768429],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.6110619,"threshold_uncertainty_score":0.7733484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233022709","doi":"10.2165/00128413-200615320-00042","title":"Health Canada has warned consumers about counterfeit and unapproved products for avian influenza.","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Counterfeit; Medicine; Influenza A virus subtype H5N1; Pharmacy; Virology; Advertising; Environmental health; Commerce; Business; Family medicine; Virus; Political science; Law","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04094740791769242,"gpt":0.2938180971714604,"spread":0.252870689253768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002263471,0.0003595962,0.0002978554,0.001027059,0.00691125,0.003328903,0.0009875622,0.007190298,0.03185838],"category_scores_gemma":[0.007349941,0.0002691792,0.0005151898,0.001145079,0.002112151,0.001157935,0.001049685,0.006846666,0.003826315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01111556,"about_ca_system_score_gemma":0.0410743,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8628297,"about_ca_topic_score_gemma":0.9244263,"domain_scores_codex":[0.9968998,0.0002043068,0.00006639706,0.0001119328,0.002078309,0.0006391921],"domain_scores_gemma":[0.9898226,0.002038407,0.000439158,0.0002581925,0.005287261,0.00215436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001348487,0.0001109322,0.0166657,0.0001555718,0.00002020264,0.0004135538,0.0008935457,0.00009384815,0.001382743,0.007073702,0.8983976,0.07465775],"study_design_scores_gemma":[0.00001758796,0.00006772087,0.02262471,0.0001802698,0.0000305389,0.0002229961,0.001698145,0.000156915,0.001133038,0.0006314558,0.9732028,0.00003388785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.05073338,0.01288921,0.001391779,0.5586826,0.008439299,0.0001945123,0.002751208,0.0005668344,0.3643512],"genre_scores_gemma":[0.2064286,0.01349573,0.00296804,0.2598384,0.00249612,0.00005713751,0.002123373,0.0002149699,0.5123777],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1371703,"threshold_uncertainty_score":0.2759562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233820458","doi":"10.2165/00128413-200514910-00055","title":"The Therapeutic Products Directorate of Canada has issued a Notice of Compliance for metformin","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Metformin; Compliance (psychology); Pharmacy; Intensive care medicine; Family medicine; Diabetes mellitus; Law; Political science; Endocrinology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.5281201482468323,"gpt":0.440615957599408,"spread":0.08750419064742432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0166384,0.0005771214,0.001199735,0.003498967,0.005533981,0.003599028,0.002539278,0.01377366,0.03269598],"category_scores_gemma":[0.04761638,0.00080412,0.001537464,0.002891957,0.001600425,0.000927994,0.001314799,0.0104378,0.00793355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01639101,"about_ca_system_score_gemma":0.09669387,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6717935,"about_ca_topic_score_gemma":0.8289697,"domain_scores_codex":[0.9784427,0.002073911,0.001714961,0.0006892697,0.01399503,0.003084218],"domain_scores_gemma":[0.9185604,0.01816081,0.003794326,0.003006957,0.04833444,0.008143048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000264907,0.0002553777,0.003603265,0.0001379256,0.00002865157,0.0001628053,0.0001138556,0.00009653273,0.0006168831,0.00457391,0.9553121,0.03483375],"study_design_scores_gemma":[0.0001503346,0.0001833041,0.02012944,0.0001804079,0.00005318194,0.0001341827,0.000119967,0.0003769365,0.0009582067,0.0004376587,0.9772074,0.00006902592],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.02168391,0.005541239,0.00555037,0.3512077,0.03665904,0.003865305,0.02552531,0.00257014,0.547397],"genre_scores_gemma":[0.07030563,0.003500284,0.01175847,0.1681598,0.007270936,0.000955766,0.01343969,0.0006359413,0.7239735],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.3282065,"threshold_uncertainty_score":0.6602788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236537247","doi":"10.2165/00128413-200313780-00008","title":"Statin therapy cost saving for prevention of CVD in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Intensive care medicine; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03379908012347198,"gpt":0.3110744887768535,"spread":0.2772754086533815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661572,0.0002843403,0.0006093354,0.001610032,0.001753483,0.002062014,0.001096796,0.001237442,0.006999635],"category_scores_gemma":[0.005530342,0.0004373749,0.001052583,0.003099386,0.0005260411,0.0004680411,0.0005981634,0.001348651,0.0002260844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07384063,"about_ca_system_score_gemma":0.1589548,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.994121,"about_ca_topic_score_gemma":0.9968694,"domain_scores_codex":[0.9983546,0.0001633244,0.0001121395,0.00009051668,0.0007393529,0.0005400379],"domain_scores_gemma":[0.9965258,0.0003617352,0.0003757396,0.0000499795,0.001140873,0.001545841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005426933,0.0008274796,0.5824527,0.001282002,0.001552382,0.001990243,0.0006412678,0.01297602,0.001499934,0.01406266,0.1570155,0.2202729],"study_design_scores_gemma":[0.001170638,0.0003522292,0.941807,0.0004730247,0.001338846,0.0008344395,0.0008861355,0.01082551,0.0005209563,0.001141449,0.04054994,0.00009980216],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8090156,0.02586654,0.0006206023,0.08749983,0.001052124,0.0003187789,0.02235611,0.0001866518,0.05308379],"genre_scores_gemma":[0.9718759,0.008060934,0.001049196,0.004405687,0.0003015804,0.00004754003,0.002652735,0.00003339982,0.01157299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07384063,"threshold_uncertainty_score":0.5357538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253209358","doi":"10.2165/00128413-200213670-00012","title":"COX-2 inhibitor use increased after formulary listing in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Listing (finance); Pharmacy; Family medicine; Business","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01691755257048687,"gpt":0.220593493756027,"spread":0.2036759411855401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002199676,0.0001471984,0.0002541465,0.001005193,0.001381814,0.001145208,0.0008328092,0.0006397219,0.007117775],"category_scores_gemma":[0.002692869,0.0002172051,0.0003943635,0.003017651,0.0003303926,0.0004228464,0.0003767323,0.001144446,0.0003375302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02287357,"about_ca_system_score_gemma":0.03103111,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9905657,"about_ca_topic_score_gemma":0.9936621,"domain_scores_codex":[0.9993334,0.00003682517,0.00004306137,0.0000616153,0.0002570442,0.0002680508],"domain_scores_gemma":[0.9969413,0.0002151326,0.0006726969,0.00004588547,0.001402128,0.0007229163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004053029,0.00009813991,0.9719686,0.00006817026,0.00005342766,0.0006517796,0.0005511619,0.0001953922,0.0005156345,0.0002901333,0.006778183,0.01842413],"study_design_scores_gemma":[0.00001548893,0.00003172944,0.9944254,0.00003138554,0.00002883006,0.0001570281,0.0007648475,0.0002327721,0.0001641014,0.00002082009,0.00411857,0.000009007126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752593,0.001710393,0.0001096842,0.004104188,0.0001009422,0.00003983982,0.007789623,0.0000515716,0.0108345],"genre_scores_gemma":[0.9884849,0.001255429,0.000139256,0.0006857071,0.00003602879,0.000009772587,0.001557111,0.00001636875,0.00781545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02287357,"threshold_uncertainty_score":0.1659601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4237317969","doi":"10.2165/00128413-200213670-00047","title":"Market news from Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0267519930970027,"gpt":0.2678704925917876,"spread":0.2411184994947849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009695478,0.0008633199,0.0007448778,0.00225594,0.006260231,0.01189365,0.001037571,0.005136615,0.1923435],"category_scores_gemma":[0.003104128,0.0005447341,0.0006300621,0.00325685,0.0009682337,0.001594416,0.001052755,0.003828735,0.05751522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01985699,"about_ca_system_score_gemma":0.03759716,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8415428,"about_ca_topic_score_gemma":0.939283,"domain_scores_codex":[0.9980914,0.00004934919,0.00003577038,0.0001320379,0.001221071,0.0004702395],"domain_scores_gemma":[0.9972236,0.0001860873,0.00006988282,0.0001089567,0.00186844,0.0005429892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001308118,0.000005525581,0.0001060799,0.00001932863,0.000001267083,0.00002294036,0.00002134223,0.00001346135,0.00002924184,0.001165699,0.9939576,0.004644372],"study_design_scores_gemma":[0.000005681676,0.000003433304,0.001205133,0.00003127826,0.000002432259,0.000009212408,0.00009975414,0.00002554216,0.00005197637,0.0001456484,0.9984144,0.000005561632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.002851397,0.01529144,0.0002070761,0.1010485,0.02267303,0.0001000032,0.009590019,0.0005610946,0.8476775],"genre_scores_gemma":[0.00451502,0.001948033,0.00006521415,0.006009185,0.0006518285,0.00001303426,0.001051783,0.00006992629,0.9856761],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1923435,"threshold_uncertainty_score":0.6434531,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230932386","doi":"10.2165/00128413-200715990-00047","title":"Health Canada has granted expanded approval of lumiracoxib [Prexige; Novartis] for the treatment of acute and chronic osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Pharmacy; Alternative medicine; Physical therapy; Intensive care medicine; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01777054040401422,"gpt":0.2917364214198742,"spread":0.2739658810158599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339671,0.000489609,0.000723569,0.001290754,0.001730499,0.001383569,0.0009557947,0.002517665,0.03055227],"category_scores_gemma":[0.002552752,0.0003026986,0.0009370495,0.0007851869,0.001038359,0.0002908627,0.0006834805,0.002859531,0.004255975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006766068,"about_ca_system_score_gemma":0.03423879,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3019677,"about_ca_topic_score_gemma":0.6485081,"domain_scores_codex":[0.9984584,0.000192586,0.0000469649,0.00008849967,0.0008248003,0.000388714],"domain_scores_gemma":[0.9956051,0.0005430181,0.0001926444,0.00008843042,0.002168035,0.00140276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00333797,0.0008538603,0.009369525,0.000717539,0.0001829446,0.00251668,0.0001308849,0.0004116694,0.02256414,0.005807365,0.6161721,0.3379353],"study_design_scores_gemma":[0.001403967,0.001180165,0.02976317,0.0002011317,0.0001472501,0.001728706,0.00009600112,0.0005902171,0.003874441,0.0003372035,0.9606269,0.0000509516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.09301571,0.08717605,0.00439287,0.132536,0.01835709,0.001905754,0.01252851,0.001931215,0.6481568],"genre_scores_gemma":[0.3391515,0.02915508,0.01054247,0.05439904,0.005446843,0.0002650539,0.0142796,0.0002597102,0.5465007],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.6980323,"threshold_uncertainty_score":0.6004201,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234132940","doi":"10.2165/00128413-200716130-00053","title":"Biovail has launched a once-daily tramadol formulation [Ralivia] in Canada for the management of moderately severe pain","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Tramadol; Medicine; Launched; Pharmacy; Physical therapy; Anesthesia; Family medicine; Analgesic; Engineering","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06399885725976563,"gpt":0.2792984534208143,"spread":0.2152995961610487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009810611,0.0003458874,0.0004109849,0.0007061925,0.001468821,0.001463964,0.0006775261,0.001418257,0.01378845],"category_scores_gemma":[0.001576828,0.000199995,0.0003301392,0.000406025,0.001036135,0.0004114804,0.0004263696,0.001853666,0.001257502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004635804,"about_ca_system_score_gemma":0.0174094,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2873504,"about_ca_topic_score_gemma":0.5902008,"domain_scores_codex":[0.9994386,0.0000872579,0.00001983685,0.00004650108,0.0002836295,0.000124169],"domain_scores_gemma":[0.9978858,0.0002871996,0.0001492905,0.00004405009,0.0009416285,0.0006920591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00666883,0.002466569,0.0163035,0.001037301,0.0001914837,0.00155914,0.0008312702,0.0009279593,0.09446795,0.009492114,0.0861824,0.7798714],"study_design_scores_gemma":[0.006118179,0.01669978,0.08067256,0.0008654209,0.0004295914,0.00421317,0.0009545885,0.003933092,0.05854213,0.001271071,0.826091,0.0002094372],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.4842744,0.07233344,0.009914041,0.07249312,0.007260961,0.002831505,0.005140778,0.001883327,0.3438684],"genre_scores_gemma":[0.7915616,0.01821954,0.01370909,0.009834691,0.001259388,0.0002114522,0.002155977,0.0003113061,0.162737],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.7126496,"threshold_uncertainty_score":0.5713556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255619675","doi":"10.2165/00128413-200112960-00010","title":"Antipsychotic polypharmacy in schizophrenia in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Pharmacy; Pharmacology; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02528746022205306,"gpt":0.3087349721650757,"spread":0.2834475119430226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004141828,0.0001846283,0.0004394119,0.001637279,0.002455126,0.001312312,0.0008586993,0.0007652978,0.004746474],"category_scores_gemma":[0.002698952,0.0003356903,0.0005091429,0.004245633,0.0004959984,0.0004187833,0.0006983262,0.001113602,0.0002492226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04823295,"about_ca_system_score_gemma":0.09468495,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9970608,"about_ca_topic_score_gemma":0.99854,"domain_scores_codex":[0.9991304,0.00007950976,0.00007693338,0.00005457329,0.0003330256,0.0003255706],"domain_scores_gemma":[0.9960623,0.0002011683,0.0006460028,0.00002890336,0.001418451,0.001643191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000689772,0.000264293,0.9267282,0.00029804,0.0001485425,0.0009044647,0.001095738,0.0006369114,0.0004974779,0.001370267,0.01787024,0.04949618],"study_design_scores_gemma":[0.0001101296,0.00007699624,0.9901159,0.0001170062,0.00006530188,0.0003484862,0.001428566,0.0007848391,0.00009334298,0.0001159891,0.006716324,0.00002712933],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9527765,0.009339172,0.0001725851,0.01605561,0.0002887586,0.0001005433,0.007382537,0.00003848019,0.01384599],"genre_scores_gemma":[0.9857738,0.005454855,0.000279309,0.001537255,0.00008759979,0.00002380046,0.001255739,0.00001738637,0.005570267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04823295,"threshold_uncertainty_score":0.3499562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4238567827","doi":"10.2165/00128413-200514860-00055","title":"Nicotinic acid [niacin] extended-release tablets [Niaspan] have been launched in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Niacin; Medicine; Launched; Pharmacy; Pharmacology; Nicotinic agonist; Family medicine; Internal medicine; Engineering","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04005818013570484,"gpt":0.3366964691176261,"spread":0.2966382889819212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006114577,0.0002346841,0.000351229,0.0003673036,0.001706124,0.001253404,0.0005387902,0.0007479125,0.02052648],"category_scores_gemma":[0.001424023,0.0001447614,0.000253321,0.0005267491,0.0005786416,0.0002423955,0.0004699873,0.001089194,0.002226159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009695959,"about_ca_system_score_gemma":0.03791167,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.851633,"about_ca_topic_score_gemma":0.9485587,"domain_scores_codex":[0.9994701,0.00004576251,0.00002325459,0.00004492719,0.0002799439,0.0001360681],"domain_scores_gemma":[0.9979445,0.0001202323,0.00009855234,0.00002976407,0.001242543,0.0005643892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005139393,0.0006835025,0.05253213,0.001119965,0.0001252167,0.001336642,0.0006956772,0.0003980426,0.01753965,0.01014278,0.3058654,0.6044216],"study_design_scores_gemma":[0.000419187,0.0007591416,0.1038361,0.0002063383,0.00007019141,0.0005382237,0.0005712388,0.0003353912,0.00616623,0.0002718579,0.8867884,0.00003763616],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.3053277,0.0666991,0.002909996,0.06392042,0.00375749,0.001628981,0.01766913,0.001214629,0.5368726],"genre_scores_gemma":[0.536929,0.02243944,0.007069283,0.01026311,0.0003453683,0.0001369997,0.005119877,0.0001246703,0.4175723],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.148367,"threshold_uncertainty_score":0.2984815,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233017224","doi":"10.2165/00128413-200213330-00013","title":"Inappropriate pantoprazole use in Canada despite guidelines","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pantoprazole; Pharmacy; Intensive care medicine; Internal medicine; Family medicine; Omeprazole","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2254775789564057,"gpt":0.3783929247872928,"spread":0.1529153458308871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453079,0.000212455,0.0005409559,0.001943432,0.003825177,0.002520271,0.001494311,0.001878611,0.003317787],"category_scores_gemma":[0.01898618,0.0004290371,0.0004368623,0.006153919,0.001193917,0.0007224184,0.0006910869,0.00323086,0.0002208663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04751102,"about_ca_system_score_gemma":0.1176929,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.992428,"about_ca_topic_score_gemma":0.9964265,"domain_scores_codex":[0.9950724,0.0004310385,0.000544958,0.0003291836,0.002541835,0.001080523],"domain_scores_gemma":[0.9746926,0.00292057,0.004684165,0.0002681733,0.01214262,0.005291907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000422889,0.0003069601,0.904928,0.0005254269,0.0001669636,0.003453783,0.002696222,0.0003521127,0.0004926944,0.001775945,0.033291,0.05158802],"study_design_scores_gemma":[0.0001099837,0.0001093685,0.9680225,0.0007321315,0.0002303079,0.001740427,0.003793049,0.001416782,0.0002770318,0.0003109427,0.02318617,0.00007134237],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8383635,0.02470767,0.000375599,0.07704484,0.001006308,0.0002008963,0.006103552,0.00008628427,0.05211139],"genre_scores_gemma":[0.9787157,0.006554982,0.0004518488,0.01069741,0.0001934186,0.00001861246,0.0007123359,0.00002953401,0.002626132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04751102,"threshold_uncertainty_score":0.3447181,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244333022","doi":"10.2165/00128413-200514710-00050","title":"Berlex has announced the Canadian approval of ethinylestradiol/drospirenone","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Ethinylestradiol; Drospirenone; Pharmacy; Family medicine; Gynecology; Environmental health; Research methodology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03238519109358545,"gpt":0.2717984732535745,"spread":0.2394132821599891,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581489,0.0004368896,0.0005118026,0.0008496013,0.002336736,0.001313955,0.0008627853,0.003256999,0.03816459],"category_scores_gemma":[0.00229834,0.0002796217,0.0006574331,0.0004358455,0.001013835,0.0003340276,0.0004462381,0.003164094,0.00591918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006938612,"about_ca_system_score_gemma":0.01421152,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2983338,"about_ca_topic_score_gemma":0.6479039,"domain_scores_codex":[0.9982051,0.0001084513,0.00004684493,0.0001248015,0.001214328,0.0003004949],"domain_scores_gemma":[0.9974324,0.0003204465,0.0001208492,0.00009780132,0.001304326,0.0007242125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002694085,0.0003003052,0.004445357,0.0004177454,0.0000787903,0.0015835,0.0001384928,0.0002382467,0.02439414,0.007137203,0.7221531,0.2364191],"study_design_scores_gemma":[0.0002412233,0.0002931752,0.004790457,0.00003913005,0.00002705903,0.0005025816,0.00005157105,0.0001525159,0.0046306,0.0002068121,0.9890426,0.00002239654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.05297332,0.07105035,0.005291701,0.2103506,0.03527297,0.001310457,0.01107395,0.003151119,0.6095256],"genre_scores_gemma":[0.1559933,0.01144413,0.006512517,0.03589882,0.002998659,0.0001193001,0.004069817,0.0003051751,0.7826583],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.7016662,"threshold_uncertainty_score":0.5931946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234456851","doi":"10.2165/00128413-200716160-00066","title":"Health Canada has approved anidulafungin [Eraxis; Pfizer].","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Anidulafungin; Pharmacy; Family medicine; Dermatology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02427527801991496,"gpt":0.3019655304416766,"spread":0.2776902524217617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006220393,0.0004425727,0.0007510286,0.0008677937,0.001405764,0.0009534677,0.000898711,0.002292171,0.05001401],"category_scores_gemma":[0.001596028,0.0001929023,0.0007053441,0.0006832428,0.000582456,0.0003185457,0.0003805687,0.00209647,0.007967628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003018645,"about_ca_system_score_gemma":0.01185167,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1629806,"about_ca_topic_score_gemma":0.3956313,"domain_scores_codex":[0.9991143,0.0001125427,0.000032489,0.00006757843,0.0004983218,0.0001747318],"domain_scores_gemma":[0.9988394,0.0001863458,0.0000840722,0.00003428197,0.0004633953,0.0003924374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002208948,0.0008474513,0.004496961,0.0008333434,0.00009480966,0.001525948,0.00006319391,0.0003085615,0.01361723,0.003325192,0.5512203,0.421458],"study_design_scores_gemma":[0.001011968,0.0009990117,0.00773143,0.0003054504,0.0001255156,0.002370515,0.0001040043,0.0008494778,0.005849656,0.0006737245,0.9799415,0.00003778853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0538911,0.1394107,0.007112151,0.1191102,0.01124473,0.001886902,0.0134498,0.003848802,0.6500456],"genre_scores_gemma":[0.3290341,0.06756892,0.01519294,0.03910198,0.002439357,0.0003711759,0.01089465,0.0003758403,0.5350209],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.8370194,"threshold_uncertainty_score":0.3240639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248803141","doi":"10.2165/00128413-200213480-00012","title":"Amiodarone lowers costs for atrial fibrillation in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Amiodarone; Atrial fibrillation; Cardiology; Internal medicine; Dronedarone; Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06332727414332998,"gpt":0.3143081856551948,"spread":0.2509809115118649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003283788,0.0001648534,0.0003410168,0.0008593063,0.001379016,0.0009829876,0.0008031134,0.0007272707,0.00565986],"category_scores_gemma":[0.004788511,0.0002169437,0.0004527766,0.001562697,0.0003008959,0.0003629708,0.0003830701,0.0009207263,0.0001572408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03197546,"about_ca_system_score_gemma":0.08070597,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.987209,"about_ca_topic_score_gemma":0.9940593,"domain_scores_codex":[0.999266,0.00008323229,0.00003908724,0.00003379114,0.0003000487,0.0002778837],"domain_scores_gemma":[0.9969168,0.0002667668,0.0003186211,0.00002866714,0.001103337,0.001365839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001592816,0.0004897738,0.7326845,0.0004523782,0.0005232402,0.00109779,0.0004463008,0.00378759,0.0007675897,0.003014931,0.1121176,0.1430256],"study_design_scores_gemma":[0.0006523709,0.000172156,0.9734915,0.0001548524,0.0003470486,0.0004592292,0.0005886061,0.003187932,0.0003128006,0.0005360773,0.02006065,0.00003674939],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8639143,0.008744954,0.0003557251,0.06685433,0.0005853926,0.0001438967,0.01048824,0.000122377,0.04879073],"genre_scores_gemma":[0.9871783,0.002772206,0.0003804392,0.002553164,0.0001821408,0.00002770457,0.001341833,0.0000156992,0.005548587],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03197546,"threshold_uncertainty_score":0.2319993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241129018","doi":"10.2165/00128413-200012260-00049","title":"Ropinirole: sudden onset of sleep warning issued in Canada","year":2000,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ropinirole; Medicine; Sleep (system call); Pharmacy; Psychiatry; Internal medicine; Family medicine; Agonist","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.009307827362471868,"gpt":0.2671578414079682,"spread":0.2578500140454963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002305107,0.0002790986,0.0003367478,0.0009364835,0.003294712,0.0009997536,0.0006014695,0.002272197,0.004965985],"category_scores_gemma":[0.001605841,0.00023107,0.0002433732,0.0008957859,0.0005125773,0.0002640245,0.0004544166,0.002545185,0.0006072471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01319803,"about_ca_system_score_gemma":0.02677983,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9315798,"about_ca_topic_score_gemma":0.9715793,"domain_scores_codex":[0.999607,0.00001471251,0.00003014709,0.00002771002,0.0001743787,0.0001460497],"domain_scores_gemma":[0.998444,0.00009810333,0.0001519796,0.0000150313,0.0006877679,0.0006031048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003437867,0.001112578,0.4704766,0.0004929649,0.000209324,0.1741485,0.002249076,0.0007973824,0.01324784,0.002390422,0.2269404,0.1044969],"study_design_scores_gemma":[0.0005244957,0.001027661,0.82814,0.0002437709,0.0001649543,0.02403776,0.003845802,0.00240907,0.002847536,0.0005003962,0.1361012,0.0001572811],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8135591,0.006095345,0.0008389367,0.06571614,0.003119833,0.0007539663,0.008367546,0.0005081874,0.1010409],"genre_scores_gemma":[0.9317851,0.002737178,0.0006136804,0.0122385,0.0007284358,0.00003498925,0.001915064,0.00008198729,0.04986496],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.06842017,"threshold_uncertainty_score":0.1376462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246947765","doi":"10.2165/00128413-200816260-00082","title":"Extended-release bupropion approved for SAD in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bupropion; Medicine; Pharmacology; Psychiatry; Smoking cessation","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02646522397901797,"gpt":0.2701920319776858,"spread":0.2437268079986678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001726283,0.0001338401,0.0001903028,0.0002192825,0.0007524506,0.0003785313,0.0003434359,0.0004515692,0.01973246],"category_scores_gemma":[0.0005037047,0.00009678167,0.0002269499,0.0002946246,0.000267749,0.0001510101,0.0001878193,0.0008591441,0.001573364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005580769,"about_ca_system_score_gemma":0.01458417,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5717067,"about_ca_topic_score_gemma":0.8904184,"domain_scores_codex":[0.999824,0.00002245389,0.00000983568,0.00001692505,0.00006783623,0.00005898786],"domain_scores_gemma":[0.9995689,0.00002538611,0.00004659762,0.000009130051,0.0002236507,0.0001263777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005410607,0.0007188304,0.02860322,0.00128196,0.0001896848,0.002746045,0.0004039757,0.0004445232,0.02665983,0.006132191,0.3592216,0.5681875],"study_design_scores_gemma":[0.002427267,0.001981597,0.1431663,0.001114175,0.0001984615,0.005485502,0.0007880755,0.0008394506,0.007296097,0.0008509442,0.8357834,0.00006863043],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.3502052,0.06679261,0.004676537,0.0623626,0.003026645,0.00210078,0.02168332,0.000927011,0.4882253],"genre_scores_gemma":[0.7315005,0.03059805,0.004968662,0.01243017,0.0003216319,0.0002702877,0.008347836,0.0001158742,0.211447],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.4282933,"threshold_uncertainty_score":0.8616312,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4256035456","doi":"10.2165/00128413-200715930-00041","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Traditional medicine; Family medicine; Optometry; Ophthalmology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01439087432189298,"gpt":0.3084827949802439,"spread":0.294091920658351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009318619,0.000456498,0.0006124419,0.002026889,0.002576492,0.004200632,0.0007933808,0.003092931,0.09555501],"category_scores_gemma":[0.003541746,0.0004966981,0.0005555191,0.001593718,0.0006098377,0.0005524879,0.0005217798,0.002920182,0.01757477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01622471,"about_ca_system_score_gemma":0.05182379,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8057409,"about_ca_topic_score_gemma":0.9205989,"domain_scores_codex":[0.9985428,0.00004216747,0.00003993585,0.00004931871,0.001124909,0.0002010426],"domain_scores_gemma":[0.994429,0.000408928,0.0002274682,0.00009874732,0.003699137,0.001136738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008782913,0.00003873586,0.001237727,0.00006583985,0.000007230007,0.0001438116,0.00002563636,0.00009543104,0.0003402069,0.000805761,0.9729815,0.02417031],"study_design_scores_gemma":[0.00003854186,0.00004106483,0.007952723,0.00006486556,0.00001492743,0.00007869375,0.00005047362,0.0002317216,0.000454037,0.0002269898,0.9908303,0.00001565138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.01434386,0.01433794,0.001770888,0.09018544,0.02035547,0.0006111669,0.04300119,0.002211116,0.813183],"genre_scores_gemma":[0.01879868,0.004011157,0.0006690401,0.008913349,0.001479539,0.00003627405,0.006878694,0.0001719955,0.9590412],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.1942591,"threshold_uncertainty_score":0.3908063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255149466","doi":"10.2165/00128413-200715780-00050","title":"Health Canada advises of health risks with EMPowerplus","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Environmental health; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04979907539551033,"gpt":0.3510823803909179,"spread":0.3012833049954076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005254947,0.0005480828,0.0005373757,0.002601232,0.004625931,0.00378357,0.001646168,0.006751037,0.1280317],"category_scores_gemma":[0.02641647,0.0005604666,0.0008439944,0.001794062,0.00135006,0.001318101,0.001821954,0.006230048,0.01132437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0148734,"about_ca_system_score_gemma":0.1220446,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8026877,"about_ca_topic_score_gemma":0.9250709,"domain_scores_codex":[0.9946062,0.0008153183,0.0002164881,0.000221084,0.002941963,0.001198968],"domain_scores_gemma":[0.9605062,0.01027187,0.0008003881,0.0007373362,0.01399857,0.01368566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001724723,0.00004601665,0.001447354,0.00001958091,0.000005959385,0.00007299625,0.00005657295,0.00006751185,0.00004696396,0.001730963,0.9753774,0.02111139],"study_design_scores_gemma":[0.00004372343,0.0000217001,0.002597776,0.00005591192,0.00001734439,0.00006671574,0.0002366892,0.0003032829,0.0001646248,0.001147169,0.9953293,0.00001586791],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003950835,0.001890357,0.001650657,0.5146351,0.008031601,0.0003815752,0.004431719,0.001227003,0.4638011],"genre_scores_gemma":[0.03875007,0.002814894,0.005204397,0.1999173,0.003704296,0.000169327,0.002010452,0.0004391662,0.7469901],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1973123,"threshold_uncertainty_score":0.4283087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247561095","doi":"10.2165/00128413-200313820-00041","title":"A new 20mg formulation of doxycycline hyclate ['Periostat'; CollaGenex Pharmaceuticals] has been approved in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Doxycycline; Pharmacy; Pharmacology; Family medicine; Antibiotics; Microbiology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05076536241035398,"gpt":0.3241503845011009,"spread":0.2733850220907469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003443338,0.0003897452,0.0004749165,0.0004618336,0.0003813877,0.0004288891,0.0005533764,0.0005456663,0.01821688],"category_scores_gemma":[0.0001863597,0.0001794581,0.0002331119,0.0002252941,0.0003541023,0.0002378792,0.0002368659,0.0009167984,0.004281594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008794466,"about_ca_system_score_gemma":0.001426206,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01016549,"about_ca_topic_score_gemma":0.03129371,"domain_scores_codex":[0.9997974,0.00002673631,0.0000096575,0.0000358265,0.00008946224,0.00004085284],"domain_scores_gemma":[0.9998379,0.00002003546,0.00002595216,0.00001387866,0.00003234718,0.00006986698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003567535,0.001265646,0.0006515218,0.0006445444,0.00004311722,0.0002987955,0.00008445783,0.000272424,0.6155953,0.001320019,0.02758922,0.3486674],"study_design_scores_gemma":[0.003628343,0.009318191,0.0160493,0.0001867792,0.0001623971,0.002096476,0.00008320904,0.001383844,0.3454749,0.0002109484,0.6213508,0.0000548213],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.5947311,0.1043336,0.03293419,0.004881852,0.002830892,0.004958583,0.01239457,0.005911976,0.2370232],"genre_scores_gemma":[0.7594187,0.02512412,0.02465973,0.001174563,0.0003197844,0.0008856806,0.01064274,0.0002408217,0.1775339],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9898345,"threshold_uncertainty_score":0.06094152,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231741136","doi":"10.2165/00128413-200615540-00012","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ezetimibe; Atorvastatin; Medicine; Pharmacy; Pharmacology; Family medicine; Internal medicine; Statin","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04707652281454486,"gpt":0.2926426875188345,"spread":0.2455661647042896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004849723,0.0003290623,0.000888016,0.001825555,0.001745056,0.002961963,0.002033634,0.001380373,0.006653329],"category_scores_gemma":[0.03859906,0.0005711423,0.001035094,0.006172571,0.001850251,0.001020935,0.0009760425,0.002814018,0.0003108327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03480037,"about_ca_system_score_gemma":0.09211115,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9712128,"about_ca_topic_score_gemma":0.982533,"domain_scores_codex":[0.9927661,0.001082408,0.0005809501,0.0007498162,0.003903216,0.0009174385],"domain_scores_gemma":[0.9531946,0.0132212,0.009502269,0.001100693,0.0176977,0.005283518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009857035,0.0006620742,0.4921515,0.003497127,0.0009737329,0.0007734433,0.003193243,0.0007535868,0.001854101,0.00587594,0.03224986,0.4481584],"study_design_scores_gemma":[0.002269713,0.001159308,0.9319819,0.00279847,0.002643196,0.0003831897,0.003100404,0.00163259,0.00139985,0.0006357458,0.05187383,0.0001218919],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7977946,0.08864558,0.001506926,0.04236225,0.0008839092,0.0007018928,0.01003528,0.000169597,0.05789997],"genre_scores_gemma":[0.9509615,0.03663999,0.001404951,0.005134402,0.0001323196,0.00007881731,0.001816874,0.00006434956,0.003766834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03480037,"threshold_uncertainty_score":0.2524955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248712378","doi":"10.2165/00128413-200515060-00051","title":"Safety updates to Canadian labelling for Duragesic","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Pharmacy; Medical emergency; Family medicine; Criminology; Psychology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02394607577086246,"gpt":0.3393357333737358,"spread":0.3153896576028734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006984204,0.0006868718,0.0007323076,0.003414406,0.005547418,0.004243118,0.003501829,0.01009046,0.04016306],"category_scores_gemma":[0.0241972,0.0006390674,0.001575274,0.00248508,0.001834641,0.001107839,0.001059331,0.008022418,0.009749432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02038126,"about_ca_system_score_gemma":0.06250339,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6898334,"about_ca_topic_score_gemma":0.8148617,"domain_scores_codex":[0.9887542,0.001252675,0.0005892597,0.0004738714,0.007615852,0.001314175],"domain_scores_gemma":[0.9583477,0.004421107,0.001244591,0.001281328,0.03218897,0.002516382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001560163,0.00007489007,0.0009373653,0.0002769785,0.00001395002,0.0002548304,0.0002822613,0.0001370602,0.001348529,0.007105141,0.9376619,0.05175104],"study_design_scores_gemma":[0.00001857142,0.00003915234,0.001975707,0.0001612815,0.0000220837,0.0001553863,0.0001143474,0.00007568966,0.0006773729,0.0004280659,0.9963103,0.00002196637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01231257,0.01537947,0.006911206,0.2300736,0.04078059,0.00077496,0.008814961,0.003040694,0.6819119],"genre_scores_gemma":[0.07402951,0.01110739,0.01809108,0.1708759,0.00577499,0.0003259559,0.006828045,0.0009572137,0.7120099],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3101666,"threshold_uncertainty_score":0.6239865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244309416","doi":"10.2165/00128413-200615400-00068","title":"Auxilium Pharmaceuticals has received marketing approval from Health Canada for its topical testosterone gel","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Drug approval; Family medicine; Pharmacology; Marketing; Drug; Business","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03935785095437948,"gpt":0.2892082049520718,"spread":0.2498503539976923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008821069,0.000415804,0.0005669498,0.00106575,0.0009369699,0.0008740374,0.0004799679,0.001125964,0.06031097],"category_scores_gemma":[0.0007788976,0.0001578514,0.0005234563,0.0005126853,0.0003983997,0.0002195563,0.0002862326,0.001239128,0.01327173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009264784,"about_ca_system_score_gemma":0.002173436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01167958,"about_ca_topic_score_gemma":0.0311131,"domain_scores_codex":[0.9994496,0.0000959734,0.00001677367,0.00003680361,0.0003190756,0.00008179749],"domain_scores_gemma":[0.9991373,0.0002026869,0.00008191462,0.00004368371,0.000277287,0.0002570857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002133698,0.001058451,0.002808941,0.001200765,0.00004713017,0.001173998,0.0001607947,0.0001427468,0.1478889,0.003241185,0.08930157,0.7508419],"study_design_scores_gemma":[0.0006237081,0.005524196,0.02612062,0.0003221081,0.0001584417,0.006680167,0.0002601947,0.0004732962,0.1019181,0.0004668677,0.857403,0.00004928207],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.1637704,0.1621059,0.01180568,0.01593732,0.006683166,0.001215893,0.005490137,0.003938333,0.6290531],"genre_scores_gemma":[0.394023,0.03276165,0.008336561,0.00310356,0.001398,0.0001740928,0.002716092,0.0003296391,0.5571575],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.06031097,"threshold_uncertainty_score":0.2017603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212882070","doi":"10.2165/00128413-200715910-00071","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.3321649356588049,"gpt":0.4240665891210503,"spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003149988,0.0005499688,0.0007260086,0.003656202,0.004259442,0.005304715,0.001177114,0.002730465,0.05620895],"category_scores_gemma":[0.009649679,0.0005047971,0.001116215,0.003070424,0.00119654,0.0006548907,0.0008476631,0.002761706,0.01089419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03610805,"about_ca_system_score_gemma":0.1142667,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.952157,"about_ca_topic_score_gemma":0.9678574,"domain_scores_codex":[0.9929371,0.0003547469,0.0002633517,0.0004933039,0.004722932,0.001228482],"domain_scores_gemma":[0.9842003,0.0007403063,0.0003738165,0.000275233,0.01232861,0.002081688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004202416,0.0001086024,0.007277981,0.0003659675,0.00004571973,0.0003918095,0.0002397384,0.0003054213,0.0008705436,0.008221804,0.9079683,0.07378393],"study_design_scores_gemma":[0.00006638464,0.00006364276,0.0288314,0.000137163,0.0000302814,0.0000782097,0.0001921173,0.0003198928,0.0005629539,0.000277328,0.9694098,0.00003091412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.04226076,0.02571643,0.001162135,0.0395348,0.01024209,0.001037855,0.03453457,0.001010928,0.8445005],"genre_scores_gemma":[0.1202495,0.007748218,0.0008525056,0.009048986,0.0006615754,0.0001890161,0.009129057,0.0003188255,0.8518023],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05620895,"threshold_uncertainty_score":0.2619835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4254352082","doi":"10.2165/00128413-200816570-00002","title":"The 2008 clinical type 2 diabetes guidelines from the Canadian Diabetes Association (CDA) include the new class of DPP-IV* inhibitors.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology; Drug","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05587108759421896,"gpt":0.3279714595386067,"spread":0.2721003719443877,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215233,0.0006552094,0.0008433235,0.001291603,0.001194888,0.001727762,0.001286193,0.00209546,0.02027428],"category_scores_gemma":[0.005312855,0.0002532389,0.0008458574,0.002594644,0.0005416808,0.0006622681,0.0007759121,0.005630978,0.009470943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00361473,"about_ca_system_score_gemma":0.01722302,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2324305,"about_ca_topic_score_gemma":0.5008526,"domain_scores_codex":[0.9978393,0.000187072,0.0001811615,0.00007437394,0.001481083,0.0002369164],"domain_scores_gemma":[0.9942027,0.000445314,0.0003976518,0.0001162862,0.003824864,0.001013271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001315802,0.00007784534,0.0007452378,0.0002443652,0.00001340766,0.00005701819,0.00002590474,0.00003555437,0.0001502143,0.0009091019,0.8903506,0.1072593],"study_design_scores_gemma":[0.0001012268,0.00003991252,0.003896496,0.0005634316,0.00003904335,0.0002420426,0.00006277049,0.00006542972,0.0001668802,0.0003628648,0.9944423,0.0000176201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.008499066,0.2156353,0.0105427,0.255286,0.0733135,0.001177456,0.02798161,0.001461286,0.4061031],"genre_scores_gemma":[0.04855495,0.2891555,0.06611491,0.1825794,0.01585307,0.001194838,0.04425151,0.0006044875,0.3516913],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.7675694,"threshold_uncertainty_score":0.4621553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4245182772","doi":"10.2165/00128413-200615530-00070","title":"Product approvals in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2568913582669395,"gpt":0.3872280217158144,"spread":0.1303366634488748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003050723,0.0005357228,0.0007095717,0.003630858,0.004213875,0.005161868,0.001163497,0.002678418,0.0558062],"category_scores_gemma":[0.009330807,0.0004949216,0.001090271,0.003033653,0.001162759,0.0006472943,0.0008211187,0.002671235,0.01063344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03547731,"about_ca_system_score_gemma":0.1114239,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9526969,"about_ca_topic_score_gemma":0.9684248,"domain_scores_codex":[0.9932255,0.0003408238,0.0002534831,0.0004736195,0.004517539,0.001189058],"domain_scores_gemma":[0.9847344,0.0007201945,0.0003624254,0.0002671262,0.01191067,0.002005114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004402158,0.0001130623,0.007797898,0.0003716334,0.00004577705,0.0004088228,0.0002566774,0.0003184448,0.0009254559,0.008419062,0.9034267,0.07747624],"study_design_scores_gemma":[0.00006613966,0.00006560792,0.03033613,0.0001320112,0.00003053066,0.00007863481,0.000198159,0.0003333244,0.0005923636,0.0002779916,0.967858,0.00003118465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.04481821,0.02495695,0.00116995,0.03860853,0.009847208,0.00103818,0.03407288,0.001010729,0.8444774],"genre_scores_gemma":[0.1223484,0.007323367,0.0008473233,0.008499047,0.0006291334,0.0001817915,0.008835242,0.0003076274,0.8510281],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.0558062,"threshold_uncertainty_score":0.2574071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4245051009","doi":"10.2165/00128413-200514740-00048","title":"Health Canada has approved bortezomib [Velcade; Millennium Pharmaceuticals].","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Pharmacy; Pharmacology; Family medicine; Oncology; Internal medicine; Multiple myeloma","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2246281412208943,"gpt":0.51268809366099,"spread":0.2880599524400956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005963845,0.0004137706,0.0006252468,0.0007116595,0.00187221,0.001401094,0.001037553,0.00174792,0.05219409],"category_scores_gemma":[0.001780837,0.000216632,0.0006119373,0.000772335,0.0006926133,0.000318488,0.0005072257,0.002230473,0.01008633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006963014,"about_ca_system_score_gemma":0.030184,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4806408,"about_ca_topic_score_gemma":0.7510665,"domain_scores_codex":[0.998991,0.00008320557,0.00002797588,0.00006306633,0.0006248821,0.0002099548],"domain_scores_gemma":[0.998522,0.0001332532,0.00008074963,0.00003669855,0.000687696,0.0005397098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007841016,0.0004006803,0.0042897,0.0005191188,0.00005664126,0.000612342,0.00009500963,0.0001877493,0.00603332,0.003505711,0.7164144,0.2671013],"study_design_scores_gemma":[0.0002692869,0.000210165,0.004375981,0.0001527745,0.00004863531,0.0005299872,0.00009951188,0.0002129951,0.00286532,0.0003552302,0.9908575,0.00002265457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.03330292,0.06575408,0.003852539,0.1133072,0.006734433,0.00089591,0.009918763,0.002954009,0.7632802],"genre_scores_gemma":[0.2031607,0.03950015,0.009336101,0.04014246,0.0009547689,0.0001888419,0.009532009,0.0004321167,0.6967529],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.5193592,"threshold_uncertainty_score":0.9556863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239662282","doi":"10.2165/00128413-200716170-00054","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.3321649356588049,"gpt":0.4240665891210503,"spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003149988,0.0005499688,0.0007260086,0.003656202,0.004259442,0.005304715,0.001177114,0.002730465,0.05620895],"category_scores_gemma":[0.009649679,0.0005047971,0.001116215,0.003070424,0.00119654,0.0006548907,0.0008476631,0.002761706,0.01089419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03610805,"about_ca_system_score_gemma":0.1142667,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.952157,"about_ca_topic_score_gemma":0.9678574,"domain_scores_codex":[0.9929371,0.0003547469,0.0002633517,0.0004933039,0.004722932,0.001228482],"domain_scores_gemma":[0.9842003,0.0007403063,0.0003738165,0.000275233,0.01232861,0.002081688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004202416,0.0001086024,0.007277981,0.0003659675,0.00004571973,0.0003918095,0.0002397384,0.0003054213,0.0008705436,0.008221804,0.9079683,0.07378393],"study_design_scores_gemma":[0.00006638464,0.00006364276,0.0288314,0.000137163,0.0000302814,0.0000782097,0.0001921173,0.0003198928,0.0005629539,0.000277328,0.9694098,0.00003091412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.04226076,0.02571643,0.001162135,0.0395348,0.01024209,0.001037855,0.03453457,0.001010928,0.8445005],"genre_scores_gemma":[0.1202495,0.007748218,0.0008525056,0.009048986,0.0006615754,0.0001890161,0.009129057,0.0003188255,0.8518023],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05620895,"threshold_uncertainty_score":0.2619835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239001268","doi":"10.2165/00128413-200113090-00057","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02023096354187482,"gpt":0.2872669464453149,"spread":0.2670359829034401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001010061,0.0008728373,0.0007528544,0.002308494,0.006336105,0.01194641,0.001046048,0.005261838,0.1964562],"category_scores_gemma":[0.003234266,0.0005537382,0.0006459007,0.003320371,0.001008232,0.001633372,0.001076938,0.003957405,0.05921591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0203446,"about_ca_system_score_gemma":0.03814969,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.838168,"about_ca_topic_score_gemma":0.9374605,"domain_scores_codex":[0.9980612,0.00004979416,0.00003708599,0.0001334278,0.001235848,0.0004825268],"domain_scores_gemma":[0.9971848,0.0002041979,0.00007535526,0.0001128369,0.00186323,0.0005595318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001303742,0.000005345266,0.000108252,0.00002034363,0.00000124684,0.00002319103,0.00002121583,0.00001381265,0.00002748472,0.001192219,0.9938869,0.004686881],"study_design_scores_gemma":[0.000005589184,0.000003386373,0.001229285,0.00003303028,0.000002409354,0.000009204431,0.00009893017,0.00002470791,0.00004936039,0.0001492477,0.9983894,0.000005543192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.002846811,0.01559398,0.0002047394,0.1036445,0.02272904,0.0001022543,0.009752302,0.0005340647,0.8445922],"genre_scores_gemma":[0.004471176,0.002044687,0.00006449746,0.005874591,0.000665316,0.00001340168,0.001088324,0.00006946974,0.9857085],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1964562,"threshold_uncertainty_score":0.6572115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235394295","doi":"10.2165/00128413-200313800-00057","title":"Market news from Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01773726546594473,"gpt":0.2777824235633968,"spread":0.2600451580974521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009962037,0.0008076721,0.000738996,0.002188376,0.006270333,0.01142861,0.001051482,0.005041019,0.1892727],"category_scores_gemma":[0.003116167,0.0005199396,0.0006507071,0.00332799,0.001001434,0.001536938,0.001022362,0.003856556,0.05606619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02076567,"about_ca_system_score_gemma":0.04039663,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8544883,"about_ca_topic_score_gemma":0.9438511,"domain_scores_codex":[0.9981567,0.00004662703,0.00003547204,0.0001270458,0.001179694,0.0004545221],"domain_scores_gemma":[0.9972351,0.0001945643,0.00007265625,0.0001124717,0.001841763,0.0005434869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001289784,0.000005246414,0.0001089238,0.0000189671,0.000001218365,0.00002343576,0.00002243397,0.00001285876,0.0000285032,0.001200059,0.993933,0.004632438],"study_design_scores_gemma":[0.000005663393,0.000003336292,0.001217954,0.00003230687,0.000002510672,0.0000100118,0.0001052591,0.0000254505,0.00005453993,0.0001624815,0.9983748,0.000005592941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.002909649,0.01530496,0.000216005,0.1033895,0.02121063,0.0001016778,0.009780852,0.0005683317,0.8465184],"genre_scores_gemma":[0.004971313,0.002159907,0.00007351571,0.006423747,0.0006489679,0.00001407802,0.001053184,0.0000764441,0.9845788],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1892727,"threshold_uncertainty_score":0.6331803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241767819","doi":"10.2165/00128413-200313980-00049","title":"Health Canada has approved a new formulation of methylphenidate ['Concerta'; Janssen-Ortho Inc.] for use in children with ADHD","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Methylphenidate; Medicine; Pharmacy; Psychiatry; Family medicine; Pediatrics; Attention deficit hyperactivity disorder","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07703450529964993,"gpt":0.3326952086648549,"spread":0.255660703365205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294724,0.0002722729,0.0005210589,0.0004413373,0.0009884288,0.000616008,0.0008836725,0.001837859,0.0255735],"category_scores_gemma":[0.0008769609,0.0001904703,0.0006121566,0.0003523576,0.0004643022,0.0002759092,0.0003413683,0.001963614,0.003575504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002442829,"about_ca_system_score_gemma":0.0069928,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.165128,"about_ca_topic_score_gemma":0.4925196,"domain_scores_codex":[0.9995673,0.00006344045,0.00002233188,0.00003782664,0.0002389234,0.00007021648],"domain_scores_gemma":[0.999359,0.00007400903,0.00007025924,0.00002205019,0.0002538768,0.0002207768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003102962,0.00158132,0.006037201,0.001184211,0.0001531691,0.001256607,0.0002040311,0.000210872,0.03509698,0.002591003,0.3593898,0.5891919],"study_design_scores_gemma":[0.003206514,0.003007898,0.02790493,0.000453896,0.0002645437,0.002289545,0.0001761897,0.0006155262,0.008638668,0.0003567308,0.953028,0.00005751274],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.1937901,0.1084799,0.01122518,0.09359025,0.01324256,0.003864092,0.01485177,0.003336893,0.5576192],"genre_scores_gemma":[0.502817,0.05689463,0.02700482,0.03407035,0.002427049,0.0007555644,0.008050404,0.0003774759,0.3676028],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.834872,"threshold_uncertainty_score":0.3283337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4254520879","doi":"10.2165/00128413-200514750-00059","title":"Abbott Laboratories' lansoprazole [Prevacid] has been approved in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Lansoprazole; Pharmacy; Family medicine; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2634522031329605,"gpt":0.3845236645862825,"spread":0.121071461453322,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001400264,0.00040098,0.0007239922,0.0009213221,0.001726497,0.001679439,0.0009855016,0.002061136,0.04098004],"category_scores_gemma":[0.003239613,0.0003576886,0.0006209447,0.0009097332,0.0009498156,0.000375893,0.0005210899,0.002909043,0.009608331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00834025,"about_ca_system_score_gemma":0.03760277,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5448629,"about_ca_topic_score_gemma":0.7380167,"domain_scores_codex":[0.9983175,0.0002318796,0.0001016539,0.0001549975,0.0008307363,0.000363359],"domain_scores_gemma":[0.9949485,0.0004417767,0.0003066405,0.0001078977,0.003071304,0.001123838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002813661,0.0003913127,0.01160272,0.0006650748,0.0001107773,0.0009932426,0.0001054457,0.0003595791,0.005129551,0.006180564,0.624716,0.346932],"study_design_scores_gemma":[0.001386982,0.0008121827,0.03566045,0.0003167884,0.0001441104,0.001027055,0.0001020726,0.0006619779,0.003007431,0.000411036,0.9564227,0.00004711061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.06773016,0.07091267,0.004266139,0.1598142,0.01050654,0.0009212979,0.01524235,0.003078962,0.6675277],"genre_scores_gemma":[0.3509933,0.02544434,0.006183,0.02559332,0.002354184,0.0002106357,0.01138121,0.0004145778,0.5774254],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.4551371,"threshold_uncertainty_score":0.915635,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059851348","doi":"10.2165/00128413-200112810-00011","title":"Canada chooses its weapons in the battle against influenza","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Battle; Medicine; Virology; Ancient history; History","authors":[{"name":"Amanda Cameron","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1052284051339479,"gpt":0.3876039190417949,"spread":0.282375513907847,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005688474,0.0003809513,0.0005676792,0.002167091,0.01367519,0.009346251,0.001348512,0.003930498,0.02026069],"category_scores_gemma":[0.01144061,0.0003752005,0.0003477804,0.004240959,0.004207217,0.002035015,0.002177277,0.004899204,0.00195149],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0877222,"about_ca_system_score_gemma":0.2734917,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9891138,"about_ca_topic_score_gemma":0.9965044,"domain_scores_codex":[0.9946557,0.001189971,0.0001208979,0.000171965,0.002151545,0.001709918],"domain_scores_gemma":[0.9881295,0.001629085,0.0003221923,0.0002767727,0.004297051,0.005345466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000420781,0.0001447453,0.02572361,0.0002010782,0.00007533267,0.0001864686,0.002417106,0.0001812875,0.0003880467,0.06710475,0.8358234,0.06733344],"study_design_scores_gemma":[0.0001056785,0.0001009559,0.02671373,0.0003924373,0.00005551557,0.00005983712,0.006807807,0.0001053704,0.0004012882,0.003846833,0.9613626,0.00004794325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.03881618,0.02593729,0.0002830222,0.7413586,0.005276009,0.0001285176,0.004012071,0.00006120014,0.1841272],"genre_scores_gemma":[0.4026887,0.04084319,0.0017641,0.2081365,0.002294652,0.0001329488,0.001719229,0.0001624002,0.3422583],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9122778,"threshold_uncertainty_score":0.6364721,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205152399","doi":"10.2165/00128413-200514830-00035","title":"Is it bye-bye Bextra in the US, EU and Canada?","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02227963487045452,"gpt":0.3001602326206158,"spread":0.2778805977501613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002684396,0.0003209454,0.0006204474,0.001053393,0.005919049,0.007033246,0.00116952,0.004973751,0.04072938],"category_scores_gemma":[0.01030085,0.0003230143,0.0005594954,0.002174547,0.003639563,0.002841963,0.002002949,0.004951247,0.004082488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01786943,"about_ca_system_score_gemma":0.1075023,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9326939,"about_ca_topic_score_gemma":0.9567511,"domain_scores_codex":[0.9969428,0.0002279269,0.0001153247,0.0001901745,0.0009049153,0.00161891],"domain_scores_gemma":[0.9902973,0.0005246743,0.000390661,0.0002289606,0.004007502,0.004550996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001872048,0.0000919825,0.02237003,0.000195988,0.00004373902,0.0007595181,0.001252998,0.00007960528,0.0003184603,0.01584489,0.8457131,0.1131424],"study_design_scores_gemma":[0.00003575761,0.00003044902,0.02508629,0.0006078014,0.00003244584,0.0005528324,0.006050777,0.00007936964,0.0001457262,0.001528773,0.965802,0.00004783519],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01672283,0.03800641,0.000330078,0.8279357,0.01730173,0.00004268604,0.001140218,0.0001183692,0.098402],"genre_scores_gemma":[0.2391271,0.06659809,0.001849467,0.3076625,0.004381584,0.00007416954,0.001122137,0.0002866838,0.3788984],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0673061,"threshold_uncertainty_score":0.1362534,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255248028","doi":"10.2165/00128413-200515060-00058","title":"Cetuximab [Erbitux; Bristol-Myers Squibb, ImClone Systems] injection has been approved by Health Canada's Biologics and Genetic Therapeutics Directorate","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Bristol-Myers; Cetuximab; Family medicine; Pharmacy; Pharmacology; Internal medicine; Cancer","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2486589550439336,"gpt":0.375657940229696,"spread":0.1269989851857624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009292813,0.000320196,0.0004328637,0.0005003433,0.0006959563,0.001118211,0.0005240196,0.000668551,0.0776055],"category_scores_gemma":[0.00156143,0.0002422966,0.0002645063,0.0003865059,0.0004264181,0.0003156421,0.0003045753,0.0009531775,0.01401231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002996794,"about_ca_system_score_gemma":0.008723989,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07138503,"about_ca_topic_score_gemma":0.1858834,"domain_scores_codex":[0.9994926,0.00007394351,0.00001970912,0.00004508134,0.0002739671,0.00009472702],"domain_scores_gemma":[0.9990885,0.00009484027,0.00007150506,0.00005661189,0.000454109,0.0002344849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003991393,0.0007148228,0.005971517,0.0002931221,0.00009454915,0.0003289765,0.0001043377,0.0006372215,0.01639658,0.009068693,0.527159,0.4352398],"study_design_scores_gemma":[0.001200427,0.001011063,0.03043952,0.0001487902,0.0001208801,0.0005793873,0.00004614939,0.00204416,0.01859174,0.0004797366,0.9453108,0.00002717058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.09386753,0.01199193,0.009027215,0.02168638,0.003326321,0.00164078,0.02088336,0.002856357,0.8347202],"genre_scores_gemma":[0.1857618,0.003195072,0.005332513,0.002246496,0.0003908782,0.000148063,0.008085967,0.0002407885,0.7945984],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.928615,"threshold_uncertainty_score":0.2596163,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214588361","doi":"10.2165/00128413-200113140-00012","title":"Galantamine treatment for AD warranted in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Galantamine; Pharmacy; Psychiatry; Pharmacology; Family medicine; Internal medicine; Donepezil; Disease; Dementia","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.05737118821012451,"gpt":0.3357867796060424,"spread":0.2784155913959179,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000179001,0.0001653894,0.000252791,0.0007900094,0.002609378,0.0008514971,0.0006189815,0.0007841259,0.008028732],"category_scores_gemma":[0.00106831,0.0001413853,0.0002766069,0.001333753,0.0003712546,0.0002389471,0.0003248605,0.001260534,0.0004591694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0187668,"about_ca_system_score_gemma":0.04063915,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9572743,"about_ca_topic_score_gemma":0.9917855,"domain_scores_codex":[0.9996568,0.00002313946,0.00002367447,0.00002633886,0.0001004698,0.000169595],"domain_scores_gemma":[0.9990544,0.00004774726,0.00007855288,0.00000783462,0.0003351898,0.0004763269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001847736,0.001173496,0.4118067,0.0009363393,0.0002697861,0.0398684,0.001638983,0.0007241835,0.00533374,0.008680705,0.2071783,0.3205416],"study_design_scores_gemma":[0.001008358,0.0007367697,0.634342,0.001191703,0.0003939457,0.03167249,0.006155933,0.002374233,0.002539423,0.002424621,0.3170418,0.0001186271],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6296957,0.03095288,0.000877201,0.08550134,0.001579525,0.0003848978,0.005240147,0.0003106837,0.2454576],"genre_scores_gemma":[0.9325573,0.009942197,0.001367388,0.01105117,0.0002728237,0.00004416146,0.001300208,0.00006235306,0.04340233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04272568,"threshold_uncertainty_score":0.1361633,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246404833","doi":"10.2165/00128413-200113070-00051","title":"Canadian market news","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02235360564488778,"gpt":0.3097431214401045,"spread":0.2873895157952167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001019837,0.001041639,0.0007327163,0.004518406,0.007337691,0.01222863,0.001503675,0.004097259,0.3401849],"category_scores_gemma":[0.004263185,0.0006312492,0.0007610198,0.005695213,0.001151112,0.002182872,0.001249011,0.003202698,0.1076764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02968873,"about_ca_system_score_gemma":0.04879652,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8872281,"about_ca_topic_score_gemma":0.9539694,"domain_scores_codex":[0.9972386,0.0000659035,0.00004745584,0.0001591423,0.001952657,0.0005362878],"domain_scores_gemma":[0.9968895,0.0001547156,0.00007071553,0.0001432273,0.002253303,0.0004885415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008369918,0.000005995441,0.00008086046,0.00002511571,0.000001268176,0.00002193058,0.0000258994,0.00001568103,0.00002537621,0.004113223,0.9879314,0.007744791],"study_design_scores_gemma":[0.000002765988,0.000001582021,0.0005787709,0.00002364216,0.000001647676,0.000007120626,0.00006564162,0.00002240035,0.00002926699,0.0002566407,0.9990062,0.000004335269],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0008925177,0.005480173,0.0001351581,0.02831651,0.006926966,0.0000763784,0.005592821,0.000314536,0.9522651],"genre_scores_gemma":[0.002656203,0.0017052,0.00009774951,0.00186503,0.0003722754,0.00001230287,0.001069062,0.0000576052,0.9921645],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3401849,"threshold_uncertainty_score":0.9411462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4240272195","doi":"10.2165/00128413-200213470-00011","title":"IV heparin use higher among US vs Canadian neurologists","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Heparin; Family medicine; Internal medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04457635898650299,"gpt":0.2568608283495297,"spread":0.2122844693630267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002605712,0.000293705,0.000529029,0.001305317,0.001469459,0.00148334,0.0005492381,0.00111723,0.01306837],"category_scores_gemma":[0.004236463,0.000279794,0.0007726504,0.002150489,0.0003063932,0.000510489,0.000332603,0.001233535,0.0005082267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004429015,"about_ca_system_score_gemma":0.006529344,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.836715,"about_ca_topic_score_gemma":0.8784088,"domain_scores_codex":[0.9991288,0.00005945406,0.00006332679,0.0001091948,0.0003046277,0.0003345642],"domain_scores_gemma":[0.9977683,0.0002871656,0.0005228784,0.00005257186,0.000757803,0.0006113714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002815728,0.00005861799,0.9850917,0.00003641566,0.0001019891,0.0003158672,0.0003680541,0.00004798463,0.0002856716,0.0001383105,0.005606377,0.007667396],"study_design_scores_gemma":[0.00002235541,0.00002588106,0.996842,0.00003763988,0.00006435849,0.0005407674,0.000782804,0.00009247396,0.00006055136,0.00003608831,0.001485819,0.000009378238],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710028,0.002684597,0.0001176841,0.002745785,0.0001735798,0.00003375113,0.003238928,0.00003158674,0.01997126],"genre_scores_gemma":[0.9941386,0.0006269955,0.0001048097,0.0008179806,0.00004672083,0.000007751944,0.001068509,0.0000123352,0.003176264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.163285,"threshold_uncertainty_score":0.3284932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}